Daniel P. Petrylak, MD

Professor of Medicine (Medical Oncology) and of Urology; Professor; Co-Director, Signal Transduction Research Program

Specialties & Subspecialties

Cancer Center, Yale: Prostate and Urologic Cancers Program

Medical Oncology

Urology: General Urology | Medical Oncology

Education & Training

  • M.D., Case Western Reserve University School of Medicine (1985)
  • Residency, Bronx Municipal Hospital , Internal Medicine (1986 - 1988)
  • Fellowship, Memorial Sloan-Kettering Cancer Center , Medical Oncology (1988 - 1991)
  • Internship, Bronx Municipal Hospital , Internal Medicine (1985 - 1986)

Patient Care

Accepts New Patients? Yes | Patient Type: Adult | NA


Clinical Interests

genitourinary cancer; prostate cancer; clinical trials for men with prostate and bladder cancer.


Cancers Treated

Bladder, Genitourinary, Prostate


Board Certifications

  • Medical Oncology, Board Certified (1993)

Clinical Trials

ConditionsStudy Title
BladderA Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial Cancer
BladderGO29293: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF MPDL3280A IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL BLADDER CANCER
ProstatePhase II, open label study of the effect of GTx-758 as secondary hormonal therapy on serum PSA and serum free testosterone levels in men with metastatic castration resistant prostate cancer maintained on androgen deprivation therapy

Edit Profile